Search our Site

DD left align Updated May 2024

Download the whole GECKO deep dive here. Short on time? Check out the consice version, GECKO on the run here and the point of care tools to support offering and ordering genetic testing. 

Bottom line: Neurodevelopmental disorders (NDDs) are a group of conditions which include autism, global developmental delay (GDD) and intellectual disability (ID), as well as attention deficit hyperactivity disorder (ADHD), specific learning disorders (LD), and others. 

An NDD may have a genetic cause, such as a genetic syndrome, or complex inheritance with genetic susceptibility factors. An identifiable genetic etiology is more likely in those with co-occurring health conditions or those who have a family history of NDDs.

Genetic testing is indicated for all:

  • autistic individuals.
  • individuals with unexplained GDD and/or ID.
  • individuals with an NDD and co-occurring features suggestive of a possible genetic condition.

Genetic testing is not indicated for those with isolated ADHD, LD, speech delay or other isolated NDD.

The Canadian College of Medical Geneticists’ 2023 Position Statement recommends first-tier genetic testing be organized by non-genetics clinicians before or concurrent with a referral to genetics. This includes chromosomal microarray and, in some cases, Fragile X syndrome testing.

Identifying the genetic etiology of an NDD may provide answers for families, inform recurrence risk and medical management. Individuals with a positive result on first-tier testing benefit from referral to a genetics specialist. Negative first-tier genetic testing does not rule out the possibility of a genetic contribution and referral to a genetics specialist for consideration of second-tier testing is recommended, unless the indication for testing was isolated autism. Genetic testing may yield uncertain or unexpected results in which case a referral to a genetics specialist would be recommended.

Periodic reassessment and possible re-referral to Genetics is suggested when no genetic etiology is identified using novel testing approaches.

Note: In this resource the terms genetics and genomics are used interchangeably.  For more information about these terms please see this fact sheet from the National Human Genome Research Institute.

What are neurodevelopmental disorders?

What causes neurodevelopmental disorders?

Who might benefit from a genetic assessment for neurodevelopmental disorder?

What genetic testing is recommended for neurodevelopmental disorders?

What are the benefits and considerations of genetic testing for neurodevelopmental disorders?

What do the results of first-tier genetic investigations mean?

Surveillance and management recommendations

Resources for primary care practitioners

Resources to share with families and persons with neurodevelopmental disorders

References

 Authors: C Aldridge, MS CGC, S Morrison MS CGC, JE Allanson MD FRCPC FCCMG, S Walji MD CCFP MPH and JC Carroll MD CCFP

Highlight: What are others reading about on GECKO

A Guide to understanding prenatal screening

A Guide to understanding prenatal screening

A resource developed for pregnant persons and their providers. Everything you wanted to know about screening from deciding whether or not have it, to results…

Read more

Latest News

The GEC-KO team will be presenting at the 2021 University of Ottawa’s Annual Refresher Course

Have some questions about how Canada’s genetic non-discrimination act works and what it means for your practice?

Check out this 2022 article in Canadian Family Physician

Read more